雷帕鸣的使用说明
Sirolimus, also called sirolimus, is a new, powerful, low-toxic macrolide immunosuppressive drug. It is mainly used clinically to prevent rejection of kidney transplants. It does not inhibit calcineurin after binding to cytoplasmic proteins, so it can completely avoid the nephrotoxicity of calcineurin inhibitors (CNI). It is one of the best choices when liver or renal insufficiency occurs after organ transplantation or when CNI cannot reach the ideal drug concentration.
Since the price of Biocanrepamin in India is relatively low, many patients choose to buy the Indian version, and its use is the same as the original drug. Biocon India is one of the top three biotech companies in India. Its fully integrated business model spans the entire pharmaceutical value chain, from preclinical discovery to clinical development and commercialization. The business is customized research, clinical development and biopharmaceuticals to provide multiple revenue streams to balance development, drive innovation, deliver products and accelerate growth.
Rapamin tablets should only be used by physicians experienced in immunosuppressive therapy and in the management of kidney transplant patients. Patients should not take medication blindly. Rapamin needs to be started as soon as possible after transplantation. The recommended loading dose of rapamycin for renal transplant patients is 6 mg and the maintenance dose is 2 mg/day. Tablets need to be swallowed whole and not chewed or broken. If the patient has difficulty swallowing, an oral solution should be chosen. Rapamin can be taken with or without food. If the dosage needs to be adjusted, it should be done under the advice of a doctor.
Tetracene macrolides are potentially new and potent immunosuppressants with less toxicity discovered so far, providing a new treatment alternative for transplant recipients. Patients need to follow the doctor's instructions carefully and use the medicine in the correct way during the treatment process. If there are special circumstances, please inform the doctor in time.
Recommended related hot articles: /newsDetail/86857.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)